An interview with Mohammed Abouelsoud: Parkinson’s Disease Neurostimulation Technology
Biography
I’m Mohammed Abouelsoud, CEO of The Mind Company, where we develop non-invasive neurostimulation devices for Parkinson’s disease and other neurological conditions. My background combines biomedical engineering expertise with a passion for improving the lives of patients and families affected by movement disorders.
Can you tell me more about your Advocacy?
My advocacy focuses on advancing breakthrough neurotechnology solutions for Parkinson’s patients while building awareness about innovative treatment options. I work directly with patients, caregivers, and healthcare providers to bridge the gap between cutting-edge research and real-world patient care.
What is your passion and how did you get involved in Parkinson’s awareness and hope for a cure?
My passion stems from witnessing the profound impact that innovative neurostimulation technology can have on patients’ daily lives, from reducing tremors to improving mobility and quality of life. I became involved after seeing the urgent need for non-invasive, accessible treatment options that patients could use at home.
What type of goals do individuals with Parkinson’s have when seeing your Advocacy?
Individuals with Parkinson’s who learn about our advocacy typically hope to access cutting-edge treatment options that can reduce their symptoms and improve their independence. They’re seeking alternatives to traditional medications with fewer side effects and greater control over their treatment journey.
What type of training and how long are the programs?
Our programs involve 15-minute neurostimulation sessions conducted over 30-minute appointments during a 3-week treatment period. We’re developing remote clinical trials that allow patients to meet with our doctors virtually and receive stimulation treatments through our clinical trial platform from the comfort of their homes.
What effect can your Advocacy have on an individual with Parkinson’s?
Our advocacy can help individuals with Parkinson’s gain access to innovative neurostimulation treatments that have shown promise in reducing tremors, improving gait, and enhancing overall motor function. Patients often report feeling more balanced, stable, and experiencing reduced tremor intensity after treatment.
What would you like to see as a future goal for your Advocacy?
I’d like to see our advocacy lead to wider insurance coverage for neurostimulation devices and greater integration of these technologies into standard Parkinson’s care protocols. We’re also developing treatments specifically for caregivers, recognizing that supporting the entire care team is essential for optimal patient outcomes.
What events do you participate in?
We focus heavily on online engagement, hosting podcasts, webinars, and virtual events that connect with the Parkinson’s community both locally and internationally. This digital approach allows us to reach patients and caregivers who may not be able to attend in-person events due to mobility challenges.
How does this also assist the caregivers?
Our approach assists caregivers by providing them with objective data about treatment progress and giving them tools to help monitor their loved one’s symptoms. We’re also developing dedicated treatments for caregivers themselves, recognizing that their wellbeing directly impacts patient care quality.
How can someone get in touch?
You can reach me at mo@uthemind.com or visit our website at https://uthemind.company/ for more information about our research, clinical trials, and advocacy efforts.
What is your website?
How can others also become advocates for awareness?
Others can become advocates by sharing patient stories, participating in clinical research, and helping raise awareness about innovative treatment options in their communities. Supporting organizations that fund Parkinson’s research and connecting patients with emerging therapies are also powerful ways to advocate.
In your opinion, what is the key to effective advocacy?
The key to effective advocacy is combining scientific rigor with genuine compassion for patients and families. It’s about translating complex research into understandable benefits while ensuring that patient voices and experiences guide our innovation efforts.
How can we better fundraise to support a cure for Parkinson’s?
We need to showcase the tangible impact of breakthrough technologies and connect donors directly with patient success stories. Demonstrating how funds translate into real-world improvements in patients’ daily lives creates more meaningful and sustainable support.
What other activities do you undertake to help improve and support your daily living? (Exercise and alternative remedies)
While my focus is on developing technology solutions, I strongly believe in the importance of comprehensive care including physical therapy, exercise programs like Rock Steady Boxing, and maintaining strong support networks. Our technology works best when integrated with these holistic approaches to wellness.
Why should people who don’t have Parkinson’s care about this?
Parkinson’s affects entire families and communities, not just patients. The innovative treatments we develop for Parkinson’s often have applications for other neurological conditions, potentially benefiting millions of people who may face these challenges in the future.
Have you had any family members or relatives affected by Parkinson’s disease?
My motivation comes from working closely with patients and witnessing firsthand how this disease impacts not just individuals but entire family systems. Each patient story reinforces my commitment to advancing accessible, effective treatments.
If you had one song that would tell us more about you or represent your life, which song would it be?
“Here Comes the Sun” by The Beatles – it represents hope, innovation, and the belief that brighter days are ahead for the Parkinson’s community through advancing technology and compassionate care.
If you had one final statement or quote you could leave for the Parkinson’s community, what would it be?
“Innovation thrives when we combine cutting-edge science with unwavering hope. Every patient who participates in research, every caregiver who shares their story, and every advocate who raises awareness is helping to build a future where Parkinson’s no longer limits what’s possible.”
__________________________________________________________
TogetherForSharon® In memory of my mother, Sharon to voice awareness & hope for a Parkinson’s Disease cure. Sharon’s Son, George